Evidence map›Paper›PMID 28342091›Full record

ArticlePsychopharmacology2017

Both nicotine reward and withdrawal are enhanced in a rodent model of diabetes.

Joseph A Pipkin, Bryan Cruz, Rodolfo J Flores, Cecilia A Hinojosa, Luis M Carcoba, Melissa Ibarra, Wendy Francis, Arbi Nazarian, Laura E O'Dell

Abstract read
In one paragraph

Article in Psychopharmacology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
1.0field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 18 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Insulin modulates the strong reinforcing effects of nicotine and changes in insulin biomarkers in a rodent model of diabetes.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2019
    Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Joseph A PipkinDepartment of Psychology, The University of Texas at El Paso, 500 West University Avenue, El Paso, TX, 79902, USA.
Bryan CruzDepartment of Psychology, The University of Texas at El Paso, 500 West University Avenue, El Paso, TX, 79902, USA.
Rodolfo J FloresDepartment of Psychology, The University of Texas at El Paso, 500 West University Avenue, El Paso, TX, 79902, USA.
Cecilia A HinojosaDepartment of Psychology, The University of Texas at El Paso, 500 West University Avenue, El Paso, TX, 79902, USA.
Luis M CarcobaDepartment of Psychology, The University of Texas at El Paso, 500 West University Avenue, El Paso, TX, 79902, USA.
Melissa IbarraDepartment of Psychology, The University of Texas at El Paso, 500 West University Avenue, El Paso, TX, 79902, USA.
Wendy FrancisDepartment of Psychology, The University of Texas at El Paso, 500 West University Avenue, El Paso, TX, 79902, USA.
Arbi NazarianDepartment of Pharmaceutical Sciences, Western University of Health Sciences, 309 East Second Street, Pomona, CA, 91766, USA.
Laura E O'DellDepartment of Psychology, The University of Texas at El Paso, 500 West University Avenue, El Paso, TX, 79902, USA. lodell@utep.edu.
The University of Texas at El Paso · USWestern University of Health Sciences · US

Funding

Phase II of BUILDing SCHOLARSUL1GM118970 · NIGMS · UNIVERSITY OF TEXAS EL PASO · PI ALEY, STEPHEN B, BOLAND, THOMAS · 2015 to 2023
$17.9M
Phase II of BUILDing SCHOLARS - Student Training CoreTL4GM118971 · NIGMS · UNIVERSITY OF TEXAS EL PASO · PI ALEY, STEPHEN B, BOLAND, THOMAS · 2015 to 2023
$9.9M
Phase II of BUILDing SCHOLARS - Research Enrichment CoreRL5GM118969 · NIGMS · UNIVERSITY OF TEXAS EL PASO · PI ALEY, STEPHEN B, BOLAND, THOMAS · 2015 to 2023
$7.4M
Sex Differences in the Mechanisms that Promote Nicotine Reward and WithdrawalR01DA021274 · NIDA · UNIVERSITY OF TEXAS EL PASO · PI ODELL, LAURA ELENA · 2007 to 2019
$4.4M
UTEP DIDARP: Vulnerability Issues in Drug Abuse (VIDA)R24DA029989 · NIDA · UNIVERSITY OF TEXAS EL PASO · PI CASTANEDA, EDWARD · 2011 to 2015
$2.1M
Summer Mentoring And Research Training: Methods In Neuroscience of Drug-abuse (SMART-MIND)R25DA033613 · NIDA · UNIVERSITY OF TEXAS EL PASO · PI Karina C Canaba, LAURA ELENA ODELL · 2012 to 2026
$1.5M
Insulin mechanisms of diabetes-evoked enhancement of nicotine rewardR15DA040130 · NIDA · WESTERN UNIVERSITY OF HEALTH SCIENCES · PI NAZARIAN, ARBI · 2015 to 2016
$546k
NIDA NIH HHS HHSN271201600057CNIDA NIH HHS R01 DA021274NIDA NIH HHS R15 DA040130NIDA NIH HHS R24 DA029989NIDA NIH HHS R25 DA033613NIGMS NIH HHS RL5 GM118969NIGMS NIH HHS TL4 GM118971NIGMS NIH HHS UL1 GM118970
6 · The paper itself

Abstract

rationaleIt is presently unclear whether diabetic rats experience greater rewarding effects of nicotine and/or negative affective states produced by nicotine withdrawal.

objectiveThe present study utilized a rodent model of diabetes to examine the rewarding effects of nicotine and negative affective states and physical signs produced by withdrawal.

methodsSeparate groups of rats received systemic administration of either vehicle or streptozotocin (STZ), which destroys insulin-producing beta cells in the pancreas and elevates glucose levels. Place conditioning procedures were utilized to compare the rewarding effects of nicotine (conditioned place preference; CPP) and negative affective states produced by withdrawal (conditioned place aversion; CPA) in vehicle- and STZ-treated rats. CPA and physical signs of withdrawal were compared after administration of the nicotinic receptor antagonist mecamylamine to precipitate withdrawal in nicotine-dependent rats. A subsequent study utilized elevated plus maze (EPM) procedures to compare anxiety-like behavior produced by nicotine withdrawal in vehicle- and STZ-treated rats.

resultsSTZ-treated rats displayed greater rewarding effects of nicotine and a larger magnitude of aversive effects and physical signs produced by withdrawal as compared to vehicle-treated controls. STZ-treated rats also displayed higher levels of anxiety-like behavior on the EPM during nicotine withdrawal as compared to controls.

conclusionThe finding that both nicotine reward and withdrawal are enhanced in a rodent model of diabetes implies that the strong behavioral effects of nicotine promote tobacco use in persons with metabolic disorders, such as diabetes.

Indexed as

RewardAnimalsConditioning, PsychologicalDiabetes Mellitus, ExperimentalDose-Response Relationship, DrugMaleMecamylamineNicotineNicotinic AntagonistsRatsRats, WistarRodentiaSubstance Withdrawal SyndromeTobacco Use DisorderMecamylamineNicotineNicotinic AntagonistsAbstinenceAnxietyAversionDiabeticMetabolic disorderRewardSmokingStreptozotocinTobacco

Identifiers

PMID28342091
PMCPMC5437741
OpenAlexW2598883162

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.